Test

About

The TuBerculosis Vaccine Initiative (TBVI) is a Research and Innovation partnership that works to discover and develop new, safe and effective TB vaccines that are accessible and affordable for all people.

News

Biofabri appoints Rolando Pajón to strengthen the late-stage development of its Tuberculosis Vaccine Candidate

Consultation meeting advances the renewed TB Vaccine Development Pathway

Call for Early Career Researchers to join the CTVD meeting

Email

info@tbvi.eu

Phone

+31 (0) 6 1099 5196

Address

Runderweg 6
8219 PK Lelystad